OncLive

Education ▼

Register | Login

Conference Coverage

Attend An Event

State of the Science Summit

Regional Seminar Series

PER Conferences

Giants of Cancer Care

OncLive Community

Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Multiple Myeloma

Immuno-Oncology News

Gynecologic Oncology

Gastrointestinal Cancer

Colorectal Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

OncLive TV: David S. Hong, MD

<< Back to Our Featured Experts

Dr. Hong on Moving Tisotumab Vedotin to Frontline Therapy for Cervical Cancer

Dr. Hong on Moving Tisotumab Vedotin to Frontline Therapy for Cervical Cancer

Dr. Hong on the Mechanism of Action of Tisotumab vedotin in Cervical Cancer

Dr. Hong on the Mechanism of Action of Tisotumab vedotin in Cervical Cancer

Dr. Hong on the Design of the InnovaTV 201 Trial in Cervical Cancer

Dr. Hong on the Design of the InnovaTV 201 Trial in Cervical Cancer

Dr. Hong on the Safety Profile of Tisotumab Vedotin in Cervical Cancer

Dr. Hong Discusses IPI-549 in Advanced Solid Tumors

Dr. Hong Discusses IPI-549 in Advanced Solid Tumors

Oncology Specialists

ABCDEFGHIJKLMNOPQRSTUVWXYZ

S. Yousuf Zafar, MD

Gregory Zagaja, MD

Jasmine Zain, MD

Jasmine M. Zain, MD

Tal Zaks, MD, PhD

Mark M. Zalupski, MD

Dmitriy Zamarin, MD, PhD

Dan Zandberg, MD

Hassane M. Zarour, MD

Kimberly J. Van Zee, MD

Kimberly Van Zee, MD

Andrew D. Zelenetz, MD, PhD

Tian Zhang, MD

Jingsong Zhang, MD, PhD

Andrew Zhu, MD, PhD

He James Zhu, MD, PhD

Viola W. Zhu, MD, PhD

You-cai Zhu, MD, PhD

Matthew R. Zibelman, MD

Oliver Zill

Ari Zimran, MD

Jeffrey Zonder, MD

Yu (Amy) Zong

Dieter Zopf

Jo Anne Zujewski, MD

Javier Zulueta, MD

OncLive SAP

CLL Treatment in Community Oncology

Trending Now

Coronavirus and Cancer: What Oncologists Need to Know

Key Questions Surround CDK4/6 Inhibitors in HR+ Breast Cancer

Expanded Choices Emerge for Myelofibrosis Following Ruxolitinib Therapy

Key Trials in R/R Metastatic TNBC

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

Publication Bottom Border

HER2+ Breast Cancer Advances

Rapid Reviews in Oncology®

Dermatologists in Cancer Care®

Priority Report

Milestones In Medicine

Pulmonologists in Cancer Care

Neuroendocrine Tumors

Rapid Reporter®

Non-Small Cell Lung Cancer Treatment

Urologists in Cancer Care

Oncology Business News

Contemporary Radiation Oncology

Oncology Nursing News

Oncology Fellows

Precision Medicine in Oncology

Invited Presentations

Oncology Treatment Pathways®

CURE Rare Cancers-Summer 2017 Issue

HEAL Summer 2017

Extraordinary Healers Vol. 11

Border Publication

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions

iTunes

YouTube

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2019
Intellisphere, LLC. All Rights Reserved.

x